Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
At the 16th Annual General Meeting of Shareholders held on March 26, 2024, all proposed agendas—including approval of financial statements, appointment of directors and auditor, approval of remuneration limits, and granting of stock options—were approved as originally submitted.
📊 [Key Disclosure Details & Financial Highlights]
- Date of Shareholders’ Meeting: March 26, 2024
- Agenda Item 1: Approval of Financial Statements & Consolidated Financial Statements for the 16th Fiscal Year (Approved as submitted)
- Separate Financials: Total Assets KRW 203,942M / Total Liabilities KRW 17,415M / Total Equity KRW 186,527M / Revenue KRW 83,478M / Operating Loss KRW -904M / Net Income KRW 4,871M (EPS: KRW 94)
- Consolidated Financials: Total Assets KRW 256,100M / Total Liabilities KRW 108,258M / Total Equity KRW 147,842M / Revenue KRW 96,523M / Operating Loss KRW -9,737M / Net Loss KRW -3,582M (EPS: KRW -65)
- Audit Opinion: Unqualified (‘적정’) for both separate and consolidated statements
- Dividend Resolutions: No cash, in-kind, or stock dividends declared
- Executive Appointments (Approved as submitted):
- Agenda 2-1 (Executive Director): Appointment of Taeyeon Jun (3-year term, Current Vice President CAO of Alteogen)
- Agenda 2-2 (Outside Director): Re-appointment of In Young Ko (3-year term, Current Outside Director of Alteogen)
- Agenda 2-3 (Outside Director): Appointment of Sang Chul Lee (3-year term, Current Member of KSBMB)
- Agenda 3 (Standing Auditor): Re-appointment of Byung Kyu Lee (3-year term, Current Standing Auditor of Alteogen)
- Other Approved Agenda Items:
- Agenda Item 4: Approval of Director Remuneration Limit (Approved as submitted)
- Agenda Item 5: Approval of Auditor Remuneration Limit (Approved as submitted)
- Agenda Item 6: Approval of Granting Stock Options (Approved as submitted)
- Board & Auditor Composition After General Meeting: 5 Total Directors including 2 Outside Directors (40%), 1 Standing Auditor
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Why Verifying Approval of AGM Agendas and Board Composition Is Necessary
This filing is an informational disclosure notifying the final voting results of key governance agendas, including financial statement approval, executive appointments, and stock option grants, submitted at the 16th AGM.
Checking this follow-up item is necessary because the resolution of the general meeting officially finalizes the FY2023 audited financial statements and establishes the formal governance structure through the appointment of directors and auditors. Verifying that the approved financial results, updated board composition, and stock option authorizations are accurately recorded in upcoming periodic reports or future disclosures is essential to confirm the final verification of the disclosed facts.
The details can be verified in future disclosures or upcoming periodic reports on DART.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
